Agentix Corp. (AGTX)
OTCMKTS · Delayed Price · Currency is USD
0.0210
-0.0010 (-4.55%)
May 26, 2026, 9:30 AM EST
Agentix Market Cap
Agentix has a market cap or net worth of $841.41 thousand as of May 27, 2026. Its market cap has decreased by -95.20% in one year.
Market Cap
841.41K
Enterprise Value
1.19M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since June 10, 2020, Agentix's market cap has decreased from 11.57M to 841.41K, a decrease of -92.73%. That is a compound annual growth rate of -35.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 841.41K | -44.00% |
| Dec 31, 2025 | 1.50M | -78.87% |
| Dec 30, 2024 | 7.11M | 472.50% |
| Dec 14, 2023 | 1.24M | -81.27% |
| Dec 29, 2022 | 6.63M | -62.19% |
| Dec 29, 2021 | 17.54M | 1.70% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avenue Therapeutics | 1.25M |
| Lyra Therapeutics | 1.24M |
| CERo Therapeutics Holdings | 1.02M |
| Protagenic Therapeutics | 988.37K |
| Evofem Biosciences | 874.70K |
| Halberd | 777.20K |
| SQZ Biotechnologies Company | 707.79K |
| Emmaus Life Sciences | 701.88K |